GRNVAC1

Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thu, 03/31/11 - 11:55 am
FDA
rindopepimut
brain cancer
Celldex
Geron
AML
GRNVAC1
blinatumomab
Micromet
non-Hodgkin's lymphoma
acute lymphoblastic leukemia
Oncothyreon
Stimuvax
breast cancer
lung cancer
Allovectin-7
Vical
melanoma